Effect of brain lesions and of harmaline on the DOPA decarboxylase activity in the striatum of the cat.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001479:Basal Ganglia / Q000201:enzymology*; D001921:Brain / Q000502:physiology*; D002415:Cats; D004296:Dopa Decarboxylase / Q000378:metabolism*; D005470:Fluorometry; D007031:Hypothalamus / Q000502:physiology; D007211:Indoles / Q000494:pharmacology*; D008636:Mesencephalon / Q000502:physiology; D012701:Serotonin / Q000032:analysis; D013378:Substantia Nigra / Q000502:physiology
D000470:Alkaloids; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D007211:Indoles; D012701:Serotonin; D004296:Dopa Decarboxylase